How established wait time benchmarks significantly underestimate total wait times for cardiac surgery

Jean-Francois Legare1, D Li, K J Buth

  • 1Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada. jean.legare@cdha.nshealth.ca

Insights

Total wait times for cardiac surgery in Nova Scotia are more than double the reported surgical wait times. Patients presenting to emergency departments experienced shorter overall cardiac care waits compared to those seeing family physicians.

Area of Science:

  • Cardiology
  • Health Services Research

Background:

  • Traditional wait times for cardiac surgery do not encompass the full patient journey.
  • Understanding total wait times is crucial for evaluating patient access to care.

Purpose of the Study:

  • To assess and compare total patient wait times for elective coronary artery bypass graft (CABG) surgery.
  • To identify factors influencing total wait times, including geographical location and method of presentation.

Main Methods:

  • Retrospective analysis of 705 patients undergoing elective CABG surgery from 2002-2005.
  • Utilized cardiac surgery and provincial physician billing databases to track patient timelines.
  • Calculated total wait times from initial presentation to surgery.

Main Results:

  • Total wait times were significantly longer (median 109-123 days) than traditional surgical wait times (median 56 days).
  • Patients presenting to emergency departments had shorter total wait times (median 73 days) than those presenting to family physicians (median 135 days).
  • Geographical location (urban vs. rural) did not significantly impact total wait times.

Conclusions:

  • Total wait times for cardiac surgery in Nova Scotia are more than twofold longer than traditionally reported.
  • The pathway of patient presentation significantly impacts overall wait times for cardiac care.
Abstract

Related Concept Videos

Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...